GlassScriptPhysician profile
Steven M Remus
NPI 1356387625
$2,058.63
in general payments reported to CMS, 2019-2025
10 companies · $630 in 2025
The $630 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $642 · 2021: $246 · 2022: $22.02 · 2023: $146 · 2024: $372 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,148.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,062.60 | 2019-2025 | Easyfuse, Citrefix, Infinity |
| Depuy Synthes Sales INC. | $454.26 | 2021-2025 | Motoband, Crosstie, Va-Lcp |
| Smith+Nephew, INC. | $146.02 | 2024 | Grafix Pl, Stravix Pl, Collagenase Santyl |
| Organogenesis INC. | $125.00 | 2021 | |
| Medical Device Business Services, INC. | $118.42 | 2023 | |
| Kuros Biosciences USA, INC | $61.99 | 2025 | Magnetos |
| Wright Medical Technology, INC. | $42.35 | 2019 | |
| Grt US Holding, INC. | $22.02 | 2022 | |
| Medtronic, INC. | $18.37 | 2025 | Inceptiv |
| Lifenet Health | $7.60 | 2025 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Remus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.